Translated automatically – community improvements welcome.

Mesoridazine

Mesoridazin is a typical antipsychotic from the group of phenothiazines, primarily acting through dopamine D2 receptor antagonism. It is used for the treatment of schizophrenia and other psychotic disorders. Due to its side effects, particularly cardiac risks, it is now rarely used. Mesoridazin also affects serotonergic and adrenergic receptors, which may contribute to sedative effects.

Neuroleptikum

Mechanism of Action

Dopamin-D2-Antagonismus

Detailed mechanism of action

Names / Identifiers

IUPAC: Mesoridazine

mesoridazine

5588-33-0

Lidanar

Thioridazine-2-sulfoxide

TPS-23

Mesoridazina

Thioridazine thiomethyl sulfoxide

Tps23

NC-123

Mesoridazinum

Effects

Antipsychotisch

Sedierend

Angstlösend

Antiemetisch

Kardiovaskuläre Effekte

Effects described from scientific sources. Individual experiences vary.

Dosage

Safety NoteIndividual variation, start at a low dose, no medical advice.

Individual sensitivity varies. Not a dosage recommendation.

Duration

Peak2-4 hours

NotesDuration of action may vary depending on individual metabolism.

Onset1-2 hours

Total24 hours

After EffectsVariable

Risks & Warnings

Warnings

Cardiovascular diseases
Pregnancy and breastfeeding

Known Risks

medium
Mögliche kardiale Risiken und andere Nebenwirkungen.

Safer Use

Conduct regular medical check-ups.
Watch for signs of side effects.

Harm reduction tips do not replace medical advice.

Known Interactions

May interact with other centrally acting substances.

This list is not exhaustive. Interactions can have unpredictable effects.

Legal Status

ATVerschreibungspflichtig

CHVerschreibungspflichtig

DEVerschreibungspflichtig

USVerschreibungspflichtig

NotesDie Verwendung ist aufgrund von Nebenwirkungen eingeschränkt.

Not legal advice. Status may change.